Variant or sporadic Creutzfeldt-Jakob disease?

The Lancet

Volumn 375, Issue 9718, 2010, Pages 889-

  Brandel, J P ^a,c   Galanaud, D ^a   Freeman, L ^a   Laplanche, JL ^b   Haik, S ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNESIA; BEHAVIOR CHANGE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CODON; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC IMAGING; GENE MUTATION; HEADACHE; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; LEG PAIN; LETTER; MALE; MUSCLE HYPERTONIA; MYOCLONUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERSONALITY DISORDER; PRIORITY JOURNAL; RISK FACTOR; VISUAL HALLUCINATION; WESTERN BLOTTING; BRAIN; GENETICS; HETEROZYGOTE; MIDDLE AGED; NOTE; PATHOLOGY; PRION;

PRNP PROTEIN, HUMAN;

BRAIN; CODON; CREUTZFELDT-JAKOB SYNDROME; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRIONS;

EID: 77749251805     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60378-9     Document Type: Letter

References (4)

1. Kaski D., Mead S., Hyare H., et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374 (2009) 2128
2. WHO. The revision of the surveillance case definition for variant Creutzfeldt-Jakob disease (vCJD): report of a WHO consultation Edinburgh, United Kingdom 17 May 2001. http://www.who.int/csr/resources/publications/bse/WHO_CDS_CSR_EPH_2001_5 /en/ (accessed Feb 17, 2010).
3. Brandel J.P., Heath C.A., Head M.W., et al. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain. Ann Neurol 65 (2009) 249-256
4. Peden A.H., Head M.W., Ritchie D.L., et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529